|Anti-Human CD140a Therapeutic Antibody
- Product Overview
- Recombinant human monoclonal antibody expressed in CHO binding to human CD140a. Tovetumab is a monoclonal antibody designed for the treatment of cancer
- IgG2 - kappa
- The details of the immunogen for this antibody are not available.
- Species Reactivity
- Expression Host
- Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, ICC and most other immunological methods.
- Predicted N terminal
- Molecular Weight
- 144.8 kDa
- Purity >95% by SDS-PAGE.
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Tovetumab is a monoclonal antibody designed for the treatment of cancer.
- Antigen Description
- Receptor that binds both PDGFA and PDGFB and has a tyrosine-protein kinase activity.
- ATP binding; nucleotide binding; phosphatidylinositol 3-kinase binding; platelet-derived growth factor alpha-receptor activity; platelet-derived growth factor alpha-receptor activity; platelet-derived growth factor binding; platelet-derived growth factor
- Gene ID
- PDGFRA; platelet-derived growth factor receptor, alpha polypeptide; platelet-derived growth factor receptor alpha; CD140a; PDGFR2; PDGFR-alpha; PDGF-R-alpha; CD140a antigen; PDGFRA/BCR fusion; CD140 antigen-like family member A; platelet-derived growth factor receptor 2; alpha-type platelet-derived growth factor receptor; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein; CD140A; PDGFR-2; RHEPDGFRA; MGC74795;
- Download Datasheet:
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us